The Department of Defense's Defense Health Agency awarded a $1,194,425 Project Grant to The Wistar Institute of Anatomy and Biology to support a 3-year research project titled "DEVELOPING RATIONAL APPROACHES FOR ACRAL MELANOMA" under the Military Medical Research and Development program (CFDA 12.420). The grant will fund basic, translational, and clinical research aimed at developing new treatments and advancing scientific understanding of acral melanoma, a rare form of skin cancer.
As part of this project, The Wistar Institute will collaborate with the University of Pennsylvania to synthesize and provide novel S6K inhibitors for the proposed studies. This sub-award, valued at $366,803, will be overseen by Dr. Jeffrey D. Winkler to support the synthesis of these novel compounds.
Generated 8/13/24, 8:38 AM